pKDR/KDR Ratio as Possible Predictor of Response in Phase I/II Study of Erlotinib and Bevacizumab for Recurrent or Metastatic Head and Neck Cancer
American Society of Clinical Oncology
Scientific Publications
Peer-reviewed articles and conference poster presentations
All Scientific Literature Publications
-
Download Poster pKDR/KDR Ratio as Possible Predictor of Response in Phase I/II Study of Erlotinib and Bevacizumab for Recurrent or Metastatic Head and Neck Cancer
-
Download Poster Epigenetic immune cell markers for Chronic Lymphatic Leukemia (CLL)
.jpg?width=612&height=477&name=82.%20Epigenetic%20immune%20cell%20markers%20for%20Chronic%20Lymphatic%20Leukemia%20(CLL).jpg)
Epigenetic immune cell markers for Chronic Lymphatic Leukemia (CLL)
-
Download Poster Effect of Ozanimod on Circulating Leukocyte Subtypes in Patients With Relapsing Multiple Sclerosis
Effect of Ozanimod on Circulating Leukocyte Subtypes in Patients With Relapsing Multiple Sclerosis
-
Download Poster Interim biomarker analysis of etigilimab in advanced solid tumors
Interim biomarker analysis of etigilimab in advanced solid tumors
-
Download Poster Phase 1 Trial of a Combination of the VEGFR KinaseInhibitor Cediranib(AZD2171) and Bevacizumab in Advanced Malignancies
%20and%20Bevacizumab%20in%20Advanced%20Malignancies.jpg?width=612&height=321&name=99.%20Phase%201%20Trial%20of%20a%20Combination%20of%20the%20VEGFR%20KinaseInhibitor%20Cediranib(AZD2171)%20and%20Bevacizumab%20in%20Advanced%20Malignancies.jpg)
Phase 1 Trial of a Combination of the VEGFR KinaseInhibitor Cediranib(AZD2171) and Bevacizumab in Advanced Malignancies
American Association for Cancer Research